Cargando…
Hydralazine-induced vasculitis presenting with ocular manifestations
PURPOSE: The objective of the study is to report a case of ocular manifestations in a patient with hydralazine-induced vasculitis. OBSERVATIONS: An 88-year-old female was admitted for lower gastrointestinal bleeding. Nine days after admission, she developed bilateral conjunctival chemosis and inject...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020102/ https://www.ncbi.nlm.nih.gov/pubmed/35464686 http://dx.doi.org/10.1016/j.ajoc.2022.101515 |
_version_ | 1784689459468435456 |
---|---|
author | Hawn, Vivian S. Vo, Thomas A. Flomenbaum, David Gibralter, Richard P. |
author_facet | Hawn, Vivian S. Vo, Thomas A. Flomenbaum, David Gibralter, Richard P. |
author_sort | Hawn, Vivian S. |
collection | PubMed |
description | PURPOSE: The objective of the study is to report a case of ocular manifestations in a patient with hydralazine-induced vasculitis. OBSERVATIONS: An 88-year-old female was admitted for lower gastrointestinal bleeding. Nine days after admission, she developed bilateral conjunctival chemosis and injection, which rapidly progressed into grouped blistering eruptions of the periorbital skin, face, and neck. After extensive testing and evaluation, her constellation of findings was diagnosed as hydralazine-induced vasculitis. Treatment with intravenous steroids and discontinuation of hydralazine resulted in improvement of the cutaneous and ocular manifestations. Herein we describe the clinical course of an adult patient with symptoms and signs consistent with hydralazine-induced vasculitis to highlight that ophthalmological manifestations can be the first symptoms in patients with life-threatening dermatological conditions. CONCLUSIONS AND IMPORTANCE: To our knowledge, this report is the first case of hydralazine-induced vasculitis initially presenting with ocular manifestations. |
format | Online Article Text |
id | pubmed-9020102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90201022022-04-21 Hydralazine-induced vasculitis presenting with ocular manifestations Hawn, Vivian S. Vo, Thomas A. Flomenbaum, David Gibralter, Richard P. Am J Ophthalmol Case Rep Case Report PURPOSE: The objective of the study is to report a case of ocular manifestations in a patient with hydralazine-induced vasculitis. OBSERVATIONS: An 88-year-old female was admitted for lower gastrointestinal bleeding. Nine days after admission, she developed bilateral conjunctival chemosis and injection, which rapidly progressed into grouped blistering eruptions of the periorbital skin, face, and neck. After extensive testing and evaluation, her constellation of findings was diagnosed as hydralazine-induced vasculitis. Treatment with intravenous steroids and discontinuation of hydralazine resulted in improvement of the cutaneous and ocular manifestations. Herein we describe the clinical course of an adult patient with symptoms and signs consistent with hydralazine-induced vasculitis to highlight that ophthalmological manifestations can be the first symptoms in patients with life-threatening dermatological conditions. CONCLUSIONS AND IMPORTANCE: To our knowledge, this report is the first case of hydralazine-induced vasculitis initially presenting with ocular manifestations. Elsevier 2022-04-10 /pmc/articles/PMC9020102/ /pubmed/35464686 http://dx.doi.org/10.1016/j.ajoc.2022.101515 Text en Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Hawn, Vivian S. Vo, Thomas A. Flomenbaum, David Gibralter, Richard P. Hydralazine-induced vasculitis presenting with ocular manifestations |
title | Hydralazine-induced vasculitis presenting with ocular manifestations |
title_full | Hydralazine-induced vasculitis presenting with ocular manifestations |
title_fullStr | Hydralazine-induced vasculitis presenting with ocular manifestations |
title_full_unstemmed | Hydralazine-induced vasculitis presenting with ocular manifestations |
title_short | Hydralazine-induced vasculitis presenting with ocular manifestations |
title_sort | hydralazine-induced vasculitis presenting with ocular manifestations |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020102/ https://www.ncbi.nlm.nih.gov/pubmed/35464686 http://dx.doi.org/10.1016/j.ajoc.2022.101515 |
work_keys_str_mv | AT hawnvivians hydralazineinducedvasculitispresentingwithocularmanifestations AT vothomasa hydralazineinducedvasculitispresentingwithocularmanifestations AT flomenbaumdavid hydralazineinducedvasculitispresentingwithocularmanifestations AT gibralterrichardp hydralazineinducedvasculitispresentingwithocularmanifestations |